Telix upgraded on FY outlook as analysts publish bullish notes

MELBOURNE: Investors swarmed to ASX-listed Telix Pharmaceuticals after its first-quarter revenue jumped 62 per cent and

To read the full story...SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In